Harbour Investments’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$35 Hold
3
﹤0.01% 4694
2026
Q1
$50 Hold
3
﹤0.01% 4578
2025
Q4
$48 Sell
3
-8
-73% -$119 ﹤0.01% 3787
2025
Q3
$136 Hold
11
﹤0.01% 3618
2025
Q2
$127 Buy
11
+3
+38% +$36 ﹤0.01% 3504
2025
Q1
$120 Hold
8
﹤0.01% 3459
2024
Q4
$138 Hold
8
﹤0.01% 3387
2024
Q3
$148 Hold
8
﹤0.01% 3293
2024
Q2
$162 Hold
8
﹤0.01% 3178
2024
Q1
$137 Hold
8
﹤0.01% 3138
2023
Q4
$141 Buy
+8
New +$161 ﹤0.01% 3031
2021
Q4
Sell
-1,246
Closed -$35K 2798
2021
Q3
$35K Sell
1,246
-590
-32% -$18K ﹤0.01% 1976
2021
Q2
$72K Buy
1,836
+1,336
+267% +$47.9K ﹤0.01% 1581
2021
Q1
$14K Buy
+500
New +$17.1K ﹤0.01% 2398

Other funds holding CLB

Harbour Investments's CLB Position: Q2 2026 in Review

Harbour Investments held its Core Laboratories (CLB) position steady in Q2 2026 at 3 shares worth $35. The position accounts for ﹤0.01% of the portfolio, ranked #4694.

Harbour Investments first reported a position in CLB in Q1 2021 and has held it in 14 quarters since. The position peaked at $72K in Q2 2021. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Harbour Investments held 3 shares of Core Laboratories worth $35 as of Q2 2026.
  • Harbour Investments left its Core Laboratories share count unchanged in Q2 2026.
  • Core Laboratories made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #4694 holding.
  • Harbour Investments first reported a position in Core Laboratories in Q1 2021 and has held it in 14 quarters since.
  • Harbour Investments's Core Laboratories position peaked at $72K in Q2 2021.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.